The sensor RIG-I detects double-stranded RNA derived from RNA viruses. Although RIG-I is also known to have a role in the antiviral response to DNA viruses, physiological RNA species recognized by RIG-I during infection with a DNA virus are largely unknown. Using next-generation RNA sequencing (RNAseq), we found that host-derived RNAs, most prominently 5S ribosomal RNA pseudogene 141 (RNA5SP141), bound to RIG-I during infection with herpes simplex virus 1 (HSV-1). Infection with HSV-1 induced relocalization of RNA5SP141 from the nucleus to the cytoplasm, and virus-induced shutoff of host protein synthesis downregulated the abundance of RNA5SP141-interacting proteins, which allowed RNA5SP141 to bind RIG-I and induce the expression of type I interferons. Silencing of RNA5SP141 strongly dampened the antiviral response to HSV-1 and the related virus Epstein-Barr virus (EBV), as well as influenza A virus (IAV). Our findings reveal that antiviral immunity can be triggered by host RNAs that are unshielded following depletion of their respective binding proteins by the virus.
T he mammalian innate immune system surveils infected cells for the presence of microbes through the use of a defined repertoire of pattern-recognition receptors that, after sensing microbial patterns, induce the expression of type I interferons and other antiviral molecules 1, 2 . Among the pattern-recognition receptors, RIG-I (encoded by DDX58) is a key sensor for the detection of infection with RNA viruses that recognizes virus-derived doublestranded RNA (dsRNA) in the host-cell cytoplasm and initiates signaling cascades that lead to the activation of antiviral defense pathways. The C-terminal domain of RIG-I recognizes the 5′ end of the RNA ligand; that is followed by binding of RNA to the central helicase domain of RIG-I. The binding of RNA triggers a conformational change in RIG-I that allows the release of its N-terminal caspase-activation-and-recruitment domains and binding to the signaling adaptor MAVS 3, 4 .
Two well-characterized features of RIG-I ligands are a 5′ -triphosphate moiety and adjacent base-paired stretches of at least 10-19 base pairs [5] [6] [7] , as are found in the genomes or replication intermediates of several RNA viruses [8] [9] [10] . Furthermore, viral RNAs bearing 5′ -diphosphates as well as poly(U-UC) motifs are also recognized by RIG-I 11, 12 , which indicates that RIG-I is able to recognize a diverse group of viral RNA species.
Accumulating evidence indicates that in addition to its role in detecting RNA viruses, RIG-I has a critical role in mounting an innate immune response to several DNA viruses, including herpesviruses and adenoviruses [13] [14] [15] . For the detection of EBV-derived DNA, RNA polymerase III (Pol III) has been shown to convert poly(dA:dT) into short 5′ -triphosphate-containing RNAs that are recognizable by RIG-I, which suggested that Pol III acts upstream of RIG-I by producing RIG-I ligands through the conversion of dsDNA 13, 14 . However, physiological ligands recognized by RIG-I during infection with DNA viruses have not been identified.
Here we found that infection with HSV-1, a DNA virus of the Herpesviridae family, led to the nuclear-to-cytoplasmic relocalization and exposure of cellular 5S ribosomal RNA pseudogene 141 (RNA5SP141) transcripts, which allowed them to be recognized by RIG-I. RNA5SP141 was critical for induction of the expression of antiviral cytokines in response to HSV-1 and EBV, as well as to the RNA virus IAV. Our study provides evidence that RIG-I-mediated immunity can be triggered by viral perturbation of the life cycle of host-derived RNAs.
Results

Temporal role of RIG-I and DNA receptors in sensing HSV-1.
Although published evidence has indicated an important role for RIG-I in antiviral defense against DNA viruses, its contribution relative to that of other key intracellular DNA sensors, in particular cGAS 16 and IFI16 (ref. 17 ), has not been determined. We hypothesized that RIG-I and DNA sensors might serve temporally distinct roles during infection with a DNA virus, possibly due to the emergence of specific pathogen-associated molecular patterns recognized by these sensors at different times during infection. To test our hypothesis, we individually depleted primary normal human lung fibroblasts (NHLFs) of endogenous RIG-I, cGAS or IFI16 through the use of small interfering RNA (siRNA), followed by infection with HSV-1. Knockdown of endogenous RIG-I had no substantial effect on the amount of mRNA encoding the proinflammatory cytokines IFN-β (IFNB1 mRNA) or TNF (TNF mRNA) at early time points after HSV-1 infection (6 h after infection) but substantially reduced cytokine expression at a late time point (16 h after infection) ( Supplementary Fig. 1a ). In contrast, silencing of cGAS impaired induction of the expression of cytokine-encoding mRNA at both time points, while knockdown of IFI16 reduced the induction of TNF at 6 h after infection but not at 16 h after infection. To confirm the role of RIG-I in the detection of HSV-1, we assessed HSV-1-mediated upregulation of the expression of selected genes encoding cytokines and chemokines, as well as of interferon-stimulated genes (ISGs), in RIG-I-deficient (Ddx58 -/-) mouse embryonic fibroblasts ( Supplementary Fig. 1b) . The induction of genes encoding antiviral and proinflammatory molecules in Ddx58 -/mouse embryonic fibroblasts was severely attenuated relative to that of wild-type (Ddx58 +/+ ) mouse embryonic fibroblasts, particularly at late times after infection. Together these results indicated that cGAS, IFI16 and RIG-I contributed to the sensing of HSV-1 in a temporally distinct manner, with RIG-I acting specifically at later time points during infection, when potential immunostimulatory RNAs might emerge.
Binding of host RNAs to RIG-I during infection with HSV-1.
To identify the physiological RNA species recognized by RIG-I during infection with HSV-1, we purified the RNAs that immunoprecipitated together with FLAG-tagged RIG-I (FLAG-RIG-I) in transfected HEK 293T human embryonic kidney cells that had been infected with a recombinant HSV-1 containing a mutation in the gene encoding the viral serine-threonine kinase US3 that abolishes its catalytic activity (HSV-1 mut ), as the viral kinase is known to antagonize type I interferon responses 18 (Fig. 1a) . As a control, we also purified RNA species bound to FLAG-RIG-I in uninfected cells and RNA bound to FLAG-tagged green fluorescent protein (FLAG-GFP) from both HSV-1 mut -infected cells and uninfected cells. The RIG-I-bound RNA from HSV-1 mut -infected cells induced robust activation of an interferon-sensitive response element (ISRE)-driven promoter, albeit less efficiently than did RNA that immunoprecipitated together with FLAG-RIG-I from HEK 293T cells infected with Sendai virus (SeV) (an RNA virus that potently activates RIG-I and served as positive control), but the GFP-bound RNA did not ( Fig. 1b and Supplementary Fig. 2a ). In contrast, the immunostimulatory activity of RIG-I-bound RNAs extracted from uninfected cells was minimal, which indicated the emergence of RIG-I ligands during infection with HSV-1.
Next we analyzed RIG-I-bound RNA and total RNA extracted from uninfected and HSV-1 mut -infected cells by RNAseq and mapped the resulting sequences to both the HSV-1 genome and the human genome. This analysis revealed that the RIG-I-bound fraction from infected cells showed considerable enrichment for several human transcripts, relative to their abundance in the FLAG-GFP-bound fraction from infected cells; in contrast, such enrichment for viral sequences was low ( Fig. 1c ). This suggested that the RIG-I-stimulatory RNA species that emerged during infection with HSV-1 were host derived rather than virus derived. The cellular transcripts that were most abundant in the RIG-I fraction were predominantly non-coding RNAs of various subclasses, as well as some ; small Cajal body-specific RNA (scaRNA), in FLAG-RIG-I precipitates of HSV-1 mut -infected cells, presented as enrichment (log 10 values) relative to the abundance of transcripts in FLAG-GFP precipitates; labels in plot indicate the nine non-coding transcripts with the greatest enrichment. e, RNAseq analysis of the ten human transcripts (both non-coding and coding) with the greatest enrichment in FLAG-RIG-I precipitates from HSV-1 mut -infected cells and their corresponding enrichment in FLAG-RIG-I precipitates of uninfected cells (horizontal axis), presented as enrichment relative to their abundance in FLAG-GFP precipitates. f, qRT-PCR analysis of RNA5SP141 transcripts in RNA isolated as described in a from HEK 293T cells transfected to express FLAG-RIG-I or FLAG-GFP (key) and left uninfected (Mock) or infected with HSV-1 WT or HSV-1 mut (each at a multiplicity of infection (MOI) of 1) (horizontal axis); results are presented relative to those of cells transfected to express FLAG-GFP. **P < 0.005 (unpaired t-test). Data are representative of two independent experiments (b,f; mean and s.d. of n = 3 technical replicates) or are from two independent experiments (c-e).
coding RNAs (Fig. 1d,e ). Among the top ten most-abundant RNAs that bound to RIG-I specifically in HSV-1 mut -infected cells were three 5S ribosomal RNA (rRNA) pseudogene transcripts; among those, the RIG-I-bound fraction showed the greatest enrichment for RNA5SP141 ( Fig. 1e ). Quantitative RT-PCR (qRT-PCR) with primers designed to target unique regions in RNA5SP141 that are absent in the parental 5S rRNA confirmed that RIG-I precipitates from HSV-1 mut -infected cells showed considerable enrichment for RNA5SP141, but RIG-I precipitates from uninfected cells or GFP precipitates from either condition did not ( Fig. 1f ). RIG-I precipitates from cells infected with wild-type HSV-1 (HSV-1 WT ) also showed considerable enrichment for RNA5SP141 ( Fig. 1f ). Notably, endogenous RNA5SP141 purified from total cellular RNA via specific locked nucleic acid (LNA) antisense oligonucleotides detectably triggered the induction IFNB1 mRNA when transfected into NHLFs ( Supplementary Fig. 2b,c) , in contrast to RNA purified with 'scrambled' LNA antisense oligonucleotides or purified RNU1-1 RNA (which served as an additional control); this further substantiated the proposal of a role for RNA5SP141 in activation of the innate immune system.
RNA5SP141 is a direct ligand of RIG-I. We next sought to determine if RNA5SP141 is a direct and specific ligand of RIG-I. Since very little is known about the expression and function of 5S rRNA pseudogene transcripts, we inspected their parent gene, 5S rRNA, for insight into how the transcribed pseudogenes might serve as RIG-I agonists. 5S rRNA is a 120-nucleotide Pol III transcript with a highly stable secondary structure composed of helices and hairpin loops organized in a three-helix junction 19 . Structure prediction suggested that like the parental 5S rRNA, RNA5SP141 has extensive base-pairing throughout and particularly at the 5′ end ( Supplementary Fig. 3a ). We hypothesized that those doublestranded regions, along with the 5′ -triphosphate moiety that is characteristic of Pol III transcripts, might provide the molecular basis for the recognition of RNA5SP141 by RIG-I and the stimulation of innate immunity 5, 20 . Indeed, in vitro-transcribed RNA5SP141 robustly upregulated IFNB1 mRNA in both HEK 293T cells and primary NHLF cells and also induced expression of TNF and the ISGs ISG15 and DDX58 ( Fig. 2a and Supplementary Fig. 3b-d ).
The induction of cytokine-encoding genes and ISGs by RNA5SP141 was comparable to, or even greater than, the induction triggered by a 58-nucleotide rabies virus leader (RVL (ref. 12 ); called 'RABV Le ' here) in vitro transcript previously shown to activate RIG-I, while a 59-nucleotide RNA derived from an internal rabies virus sequence (RV2024-2080 (ref. 12 ); called 'RABV INT ' here), which served as negative control, was not immunostimulatory ( Fig. 2a ). In agreement with those observations, transfection of RNA5SP141 induced the dimerization of IRF3, a key transcription factor downstream of RIG-I and also other pattern-recognition receptors 21 , to levels comparable to those found after infection with SeV or transfection of RABV Le (Fig. 2b ). Depletion of RIG-I through the use of specific siRNA severely impaired the ability of RNA5SP141 to elicit an IFN-β response, but depletion of the cytosolic receptor MDA5 did not ( Supplementary Fig. 4a ); this indicated that RNA5SP141 specifically activated RIG-I. In a complementary approach, and to rule out the possibility that potential dsRNA byproducts generated during in vitro transcription triggered activation of RIG-I, we also generated a DNA construct encoding the RNA5SP141 sequence under control of the Pol III promoter U6 and assessed its immunostimulatory activity (Fig. 2c ). U6-expressed RNA5SP141 triggered robust activation of an ISRE promoter, and this activity was abolished after depletion of endogenous RIG-I, while it was unchanged after knockdown of MDA5 ( Fig. 2c ). Silencing of MDA5, however, reduced the activation of the ISRE promoter triggered by the transfection of high-molecular-weight (HMW) poly(I:C), an MDA5 agonist that served as a control. Furthermore, transfection of a DNA construct encoding U6-expressed RABV INT served as an additional control in this assay to confirm that DNA transfection itself did not induce activation of the ISRE promoter in HEK 293T cells, which are known to be defective in cGAS-STING signaling 16 (Fig. 2c) . Similarly, U6-expressed RNA5SP141 robustly induced IFNB1 transcripts in NHLFs, but RABV INT did not, and silencing endogenous RIG-I blunted the induction of IFNB1 triggered by U6-expressed RNA5SP141, but silencing MDA5 did not ( Fig. 2d ), in further support of the proposal that RNA5SP141 elicited cytokine responses via RIG-I. Phosphatase treatment of RNA5SP141 to remove the 5′ -triphosphate group, a well-defined feature of RIG-I ligands 5, 6 , abolished its ability to stimulate activation of the ISRE promoter ( Fig. 2e ). Finally, to confirm that RNA5SP141 directly interacts with and activates RIG-I, we performed an ATP-hydrolysis assay using in vitro-transcribed RNA5SP141 and purified RIG-I protein.
After binding to RIG-I, RIG-I agonists activate the ATPase of the central helicase domain of RIG-I 22 ; we found that RNA5SP141 did indeed efficiently induce the ATPase activity of RIG-I to an extent comparable to that achieved by RABV Le (Fig. 2f ). Collectively, these findings identified RNA5SP141 as a direct ligand of RIG-I.
Subcellular relocalization of RNA5SP141 by HSV-1.
To define the mechanism by which RNA5SP141 transcripts are recognized by RIG-I in HSV-1-infected cells but not uninfected cells, we first considered the possibility that infection with HSV-1 leads to changes in expression of the RNA5SP141 gene and thereby facilitates the sensing of RNA5SP141 by RIG-I. While HSV-1 is known for its ability to downregulate most host mRNAs, a phenomenon called 'virusinduced host shutoff ' , other cellular RNAs are not downregulated (e.g., tRNAs and rRNAs) or are instead upregulated (e.g., transcripts encoding proinflammatory cytokines) 23 . Both RNAseq analysis and qRT-PCR analysis showed that RNA5SP141 was upregulated about two-to threefold in HSV-1-infected cells, relative to its expression in uninfected cells; in contrast, most host RNAs were downregulated during infection with HSV-1, consistent with published reports 23 ( Supplementary Fig. 4b,c ). However, as the RIG-I-bound fraction from HSV-1-infected cells showed considerable enrichment for RNA5SP141, we considered the possibility that additional changes in the distribution or availability of RNA5SP141 must occur during the infection with HSV-1 that enable the detection of RNA5SP141 by RIG-I. While little information exists about the life cycle of 5S rRNA pseudogene transcripts, it has been established that the parental 5S rRNA is transcribed in the nucleoplasm and then either is imported into the nucleolus for ribosome biogenesis or is exported to the cytoplasm and mitochondria 24 . We hypothesized that RNA5SP141 might follow a similar pattern of transcription and transport that, when perturbed by HSV-1, allows sensing of RNA5SP141 by RIG-I in the cytoplasm. As replication of HSV-1 and its egress from the cell nucleus are known to remodel and disrupt the nuclear architecture 25 , we investigated whether infection with HSV-1 triggered nuclear-to-cytoplasmic relocalization of RNA5SP141. For this, we performed a fractionation assay of uninfected or HSV-1-infected HEK 293T cells and compared the abundance of RNA5SP141 in the cytoplasmic fraction with that in the nuclear fraction. We observed that while RNA5SP141 was predominantly nuclear in uninfected cells, it was predominantly cytoplasmic in HSV-1-infected cells (Fig. 3a) . In contrast, the cytoplasmic abundance of RNU2-1, MALAT1 and NEAT1, which are well-defined nuclear RNAs 26 , was only marginally increased after infection with HSV-1. Furthermore, RNA5SP141 remained predominantly nuclear in cells infected with SeV ( Fig. 3b ), which suggested that such induction of the relocalization of RNA5SP141 might be specific for infection with herpesviruses, or perhaps more generally for viruses that replicate in the nucleus. Collectively, these data showed that infection with HSV-1 led to increased cytoplasmic localization of RNA5SP141.
Depletion of RNA5SP141-binding proteins activates RIG-I. When
5S rRNA is present in the cytoplasm, it is normally tightly associated with proteins that facilitate its subcellular transport, increase its stability or mediate its function as part of the large ribosomal subunit 24 . At least three main cytoplasmic 5S rRNA-binding proteins have been identified; these include ribosomal protein L5 (RPL5), which associates with 5S rRNA to form 5S ribonucleoprotein particles 24 , and mitochondrial ribosomal protein L18 (MRPL18) and thiosulfate sulfurtransferase (TST; also called rhodanese), both of which facilitate the import of cytoplasmic 5S rRNA into mitochondria 27 . We hypothesized that like the parental 5S rRNA, RNA5SP141 is associated with these proteins when present in the cytoplasm. Under normal conditions, the 5S rRNA-interacting proteins can 'shield' RNA5SP141 from the immunosurveillance apparatus, whereas HSV-1-mediated shutoff of their synthesis might liberate RNA5SP141 for recognition by RIG-I. To address this hypothesis, we investigated the following: whether RNA5SP141 also bound to 5S rRNA-binding proteins; whether HSV-1 downregulated the abundance of 5S rRNA-binding proteins; and whether downregulation of those proteins increased RNA5SP141-RIG-I binding and thereby the induction of interferons. Co-immunoprecipitation analysis showed that like the parental 5S rRNA, RNA5SP141 bound to RPL5, MRPL18 and TST, although with different binding affinities ( Fig. 4a ). The abundance of mRNAs encoding 5S rRNA-binding proteins was significantly lower in HSV-1 WT -infected cells than in uninfected cells (Fig. 4b,c ), and the corresponding abundance of MRPL18 and TST protein was also reduced over the course of infection with HSV-1 WT (Fig. 4d, right) . In contrast, the abundance of MRPL18 and TST protein was not reduced in cells infected with a recombinant HSV-1 with deletion of the gene encoding the virion host shutoff protein vhs (HSV-1 Δvhs ), an mRNA-specific RNase with a major role in HSV-1-induced host translational shutoff 28 (Fig. 4d , left). Notably, despite the downregulation of RPL5 transcripts after infection with HSV-1 WT , we observed that the abundance of RPL5 protein was not reduced by infection with HSV-1 WT or HSV-1 Δvhs , consistent with published observations that ribosomal proteins are known to persist during infection with HSV-1 despite viral shutoff mechanisms 29 . RNA5SP141 bound to RIG-I efficiently during infection with HSV-1 WT but not during infection with HSV-1 Δvhs (Fig. 4e ), which suggested that virus-induced downregulation of MRPL18 and/or TST protein led to the unshielding of RNA5SP141 transcripts and thereby allowed their recognition by RIG-I and the activation of innate immunity. In support of that proposal, IFNB1 transcripts induced by infection with HSV-1 Δvhs were lower in abundance than those induced by infection with HSV-1 WT (Fig. 4f ). However, the phenomenon of greater cytokine induction by infection with HSV-1 WT than by infection with HSV-1 Δvhs was not generally applicable, as the induction of transcripts encoding the proinflammatory cytokines IL-6 and IL-8, which are known to be direct targets of vhs-mediated degradation 30 , was repressed in HSV-1 WT -infected cells ( Supplementary Fig. 4d,e ). To further investigate the role of 5S rRNA-interacting proteins in RNA5SP141-induced innate signaling, we used siRNA to deplete cells of endogenous RPL5, MRPL18 or TST in order to mimic the effects of infection with HSV-1 ( Fig. 4g ). Depletion of MRPL18 or TST markedly enhanced the abundance of IFNB1 mRNA triggered by transfection of RNA5SP141 but did not affect the response in mock-transfected cells. In contrast, depletion of RPL5 had no effect on RNA5SP141induced expression of IFNB1 mRNA. Conversely, ectopic expression of MRPL18 or TST dampened activation of the IFNB1 promoter induced by RNA5SP141 in a dose-dependent manner, but ectopic expression of RPL5 did not ( Fig. 4h ); this suggested that the interaction of RNA5SP141 with MRPL18 and TST prevents RIG-Idependent induction of cytokines. These findings support a model in which RNA5SP141 transcripts are mislocalized to the cytoplasm during infection with HSV-1 and virus-mediated downregulation of MRPL18 and TST allows access of RIG-I to these host-encoded transcripts, which results in the activation of innate immunity.
RNA5SP141-mediated cytokine response to HSV-1 and EBV.
To determine the relevance of RNA5SP141 in eliciting an antiviral response to HSV-1 infection, we performed siRNA-mediated knockdown of RNA5SP141 in NHLFs and analyzed IFNB1 and TNF transcripts in response to infection with HSV-1 ( Fig. 5a and Supplementary Fig. 5a ). The expression of HSV-1-triggered IFNB1 and TNF mRNA was much lower in cells depleted of RNA5SP141 than in cells transfected with non-targeting control siRNA and was similar to that in cells depleted of RIG-I. Notably, depletion of RNA5SP141 had no effect on IFNB1 mRNA triggered by transfection of RABV Le or HMW poly(I:C) ( Fig. 5a ), which ruled out the possibility that silencing RNA5SP141 had a general inhibitory effect on the induction of IFNB1. In support of those findings, unlike knockdown of RIG-I, silencing of RNA5SP141 had no effect on the expression of IFNB1 and TNF transcripts or secretion of IFN-β or the chemokine CCL5 triggered by infection with SeV ( Fig. 5b and Supplementary Fig. 5b ), which replicates in the cytoplasm and for which it is well established that viral RNAs, in particular RNAs from defective interfering particles, trigger RIG-I activation 9, 31 .
We next used two different LNA 'gapmers' (antisense oligonucleotides), each with a targeting sequence different from that of the siRNA used in our experiments, to deplete cells of endogenous RNA5SP141. As a control, we also used two gapmers to deplete cells of endogenous RIG-I ( Supplementary Fig. 6 ). Consistent with our results obtained with siRNA, gapmer-mediated depletion of either RNA5SP141 or RIG-I substantially reduced the induction of cytokines and chemokines in response to HSV-1 (Fig. 5c ). In contrast, gapmer-mediated knockdown of RNA5SP141 had no effect on SeV-induced IFNB1 and IFIT1 transcripts, while depletion of RIG-I abolished the induction of IFNB1 and IFIT1 by SeV, as expected ( Fig. 5d ).
We next sought to determine whether RNA5SP141 also serves as a RIG-I ligand during infection with other DNA viruses. EBV is a member of the Gammaherpesvirinae subfamily that also replicates in the nucleus and exhibits a strong host-shutoff phenotype during lytic infection 23 . In gastric adenocarcinoma cells harboring latent EBV episomes (AGS-EBV cells), in which lytic replication of EBV can be induced by treatment with sodium butyrate (NaB), we found that reactivation of EBV led to substantial upregulation of TNF, IL6 and IL8 transcripts but not of IFNB1 mRNA ( Supplementary  Fig. 7 ). Consistent with published reports indicating that RIG-I has a role in the detection of EBV 13, 14 , knockdown of endogenous RIG-I markedly reduced the induction of TNF after reactivation of EBV in AGS-EBV cells, while depletion of MDA5 had a moderate effect (Fig. 5e ). Furthermore, siRNA-mediated silencing of RNA5SP141 resulted in a profound reduction in the induction of TNF in response to reactivation of EBV, similarly to the knockdown of RIG-I ( Fig. 5e ), which suggested that the activation of RIG-I triggered by reactivation of EBV was mediated predominantly by RNA5SP141 in these cells. Silencing of RIG-I or RNA5SP141 also substantially reduced the abundance of IL6 and IL8 mRNA, as well as the secretion of IL-8, after reactivation of EBV ( Fig. 5f,g) . Moreover, we observed that the RNA5SP141-interacting proteins MRPL18 and TST were downregulated after reactivation of EBV, but RPL5 was not (Fig. 5h ), which suggested that the recognition of RNA5SP141 by RIG-I was triggered by EBV-mediated unshielding of RNA5SP141. RNA5SP141 mediates cytokine responses to IAV. Unlike most RNA viruses, IAV and other members of the Orthomyxoviridae family replicate in the host-cell nucleus. RIG-I is a key sensor of IAV infection in mammalian cells and recognizes IAV genomes and RNA derived from defective interfering particles 8, 9 . We therefore sought to determine whether RNA5SP141 also contributes to the induction of antiviral immunity in the case of infection with IAV. siRNA-mediated knockdown of RNA5SP141 markedly reduced the abundance of IFNB1 transcripts, ISG-encoded IFIT2 transcripts, and CCL5 transcripts induced by IAV in both NHLFs and HEK 293T cells (Fig. 6a-c and Supplementary Fig. 8a-c) . Similarly, depletion of RNA5SP141 diminished the induction of IFNB1 in response to IAVΔ NS1, a recombinant virus that lacks the non-structural protein NS1 and is therefore unable to efficiently antagonize innate signaling 32, 33 (Supplementary Fig. 8d ).
Consistent with our results for cytokine transcripts, siRNAmediated silencing of RNA5SP141 also reduced the secretion of IFN-β and CCL5 after infection with IAV (Fig. 6d) . Similarly, gapmer-mediated depletion of RNA5SP141 also led to a considerably reduced abundance of IFNB1, IFIT1 and ISG15 transcripts in response to IAV, although it did so less efficiently than did depletion of RIG-I (Fig. 6e,f) . In support of our model in which virusinduced downregulation of RNA5SP141-binding proteins mediates the unmasking of RNA5SP141, we also observed smaller amounts of TST and MRPL18, as well as RPL5, in IAV-infected cells than in uninfected cells (Fig. 6g) . These data indicate that during infection with IAV, both virus-derived RNAs 8, 9 and host-derived RNA5SP141 contribute to the efficient detection of IAV by RIG-I. As nuclear rearrangements and host-shutoff effects induced by IAV differ substantially from those induced by herpesviruses, the molecular mechanisms that allow the sensing of RNA5SP141 by RIG-I during infection with IAV will require further study.
Collectively, we found that RNA5SP141 is important for the RIG-I-mediated immune response to DNA viruses and at least one RNA virus (IAV) that replicates in the nucleus. However, the full range and characteristics of viruses that trigger RNA5SP141-mediated activation of RIG-I remain to be determined.
Discussion
Intracellular sensors in the innate immune system are known to function by recognizing specific molecular signatures that are unique to viral pathogens. The presence of 5′ -triphosphate RNAs in the cytoplasm is believed to serve as a means by which RIG-I discriminates between 'self ' and 'non-self ' . In contrast to viral 5′triphosphate-containing RNAs, most mature host RNAs are modified (for example, tRNAs that bear 5′ -monophosphates) or capped (for example, mRNAs) before their export from the nucleus to the cytoplasm. However, several small RNAs bearing a 5′ -triphosphate group (for example, Pol III transcripts) are also present in the host-cell cytoplasm, but whether these endogenous RNA species can activate RIG-I has remained unknown. Our study has provided evidence showing that innate immunity can be triggered by signals that follow pathogen assault and originate from the host itself. Furthermore, our finding that RNA5SP141, a Pol III transcript, activated RIG-I during infection with HSV-1 or EBV confirmed published reports showing that the Pol III-RIG-I axis is important for activation of the innate immune response to DNA viruses 13, 14 . Our work proposes a model in which the recognition of immunostimulatory cellular 5S rRNA pseudogene transcripts is normally prevented through association with specific interacting proteins. However, alterations in nuclear envelope integrity and shutoff of host protein synthesis caused by infection with herpesviruses allow innate recognition of these pseudogene transcripts. While virus-induced shutoff of host protein synthesis is believed to promote viral replication by reducing the competition between viral mRNAs and host mRNAs for export from the nucleus and the cellular translational machinery, our data suggest that this strategy also makes the virus vulnerable to detection by the innate immune system. RNA5SP141 was also critical for the initiation of RIG-Imediated cytokine responses to IAV, which is unique among RNA viruses in its nuclear replication strategy. Thus, viruses that both inhibit host protein synthesis and disrupt nuclear integrity might be more likely to inadvertently expose host-derived immunostimulatory RNAs, but further studies will be needed to determine the relevance of RNA5SP141 in eliciting innate immunity to other viruses. Additionally, although our study revealed a prominent role for RNA5SP141 in activating RIG-I-mediated immunity, it is possible that other 5S rRNA pseudogene transcripts might also contribute to activation of the innate immune response. Moreover, other endogenous RIG-I ligands that have been described include RNase L cleavage products 34 and exosomal 7SL RNA 35 . Those studies and ours here have further strengthened the concept of the activation of innate immunity through host-derived RNAs.
Interestingly, while in vitro experiments have demonstrated that blunt-ended 5′ -triphosphate dsRNAs activate RIG-I most strongly 36 , structure predictions suggest that RNA5SP141, which has the characteristic RIG-I-agonist features of a 5′ -triphosphate moiety and dsRNA stretches, is not blunt-ended, similar to endogenous RNase L cleavage products 34 and exosomal 7SL RNA 35 . This would suggest that endogenous RIG-I ligands might not all strictly adhere to the criteria of 'classic' RIG-I ligands and extends the diverse group of RNA species that RIG-I recognizes.
Studies have linked aberrant sensing of intracellular RNA or DNA to various proinflammatory or autoimmune disorders. Conceptually, these disorders arise from single-nucleotide polymorphisms in genes encoding innate sensing or signaling molecules, or enzymes that degrade viral nucleic acids, and thereby lead to the accumulation of immunostimulatory RNA or DNA ligands 37 . While our study has revealed that the recognition of cellular RNA5SP141 by RIG-I is part of the antiviral defense program, it is conceivable that this mechanism of 'self ' recognition could also be linked to the loss of immunological homeostasis due to other causes of cellular disturbance that lead to exposure of RNA5SP141. Conversely, small inhibitors designed to disrupt the interaction of RNA5SP141 with MRPL18 or TST might be useful for stimulating antiviral immunity.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-017-0005-y.
Cell culture and viruses. HEK 293T (ATCC), Vero (ATCC), NHLF (Clonetics), RIG-I-wild-type and RIG-I-deficient mouse embryonic fibroblasts 38 , as well as HEK 293T ISRE-luciferase reporter cells 39 , were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% (v/v) FBS (HyClone or Gibco), 2 mM GlutaMAX (Gibco), and 1% (v/v) penicillin-streptomycin (Gibco) under standard tissue culture conditions. AGS-EBV cells 40 (provided by N. Raab-Traub, UNC-Chapel Hill) were cultured in Ham's F12 medium supplemented with 10% (v/v) FBS, 2 mM GlutaMAX (Gibco), 1% (v/v) penicillin-streptomycin, and 500 μ g/ ml G418 (Gibco). Reactivation of EBV in AGS-EBV cells was induced by treatment with 2.5 mM sodium butyrate (NaB) (Sigma) dissolved in sterile water.
Cell lines from ATCC or Clonetics were authenticated by the vendors and were not validated further in our laboratory. Cell lines that were obtained and validated by other groups were not further authenticated. All cell lines have been regularly tested for potential mycoplasma contamination by PCR.
A US3 K220A HSV-1 mutant (HSV-1 mut ) was generated using a bacterial artificial chromosome (BAC) clone of HSV-1 strain (F) (pYEbac102; provided by Y. Kawaguchi, University of Tokyo, Japan). To facilitate detection of infected cells, pYEbac102 was modified by insertion of the gene encoding EGFP (enhanced green fluorescent protein) into mini-F vector sequences, resulting in the pYEbac102-G construct that was used for further manipulation. Expression of EGFP was driven by the human cytomegalovirus (HCMV) immediate-early (IE) promoter. En passant mutagenesis 41 was performed to introduce a mutation at sequence encoding amino acid residue 220 of the US3 protein kinase whereby the original lysine (K) was substituted with alanine (A), leading to the BAC pYEbac102-K220A-G construct. The following primers were used to amplify the PCR product that allowed for mutagenesis to occur: forward, 5 ′ -TG AC AG CA GC CA CC CA GA TT AC CC CC AA CG GG TA AT CG TG G CG G CG-GG GT GG TA CA CG AGCACTAGGGATAACAGGGTAATCGAT-3′ ; reverse, 5′ -GCAGTCGCGCCTCGTGGCTCGTGCTCGTGTACCACCCCGCCGC CACGATTACCCGTTGGGGGTCCAGTGTTACAACCAATTAACC-3′ (nucleotides in italics and bold represent the desired mutation). After confirmation of the constructs by restriction fragment length polymorphism (RFLP) and DNA sequencing (LGC Genomics), 1 μ g each of purified BAC DNA was transfected into Vero cells at 90% confluency using polyethylenimine (PEI; Polysciences). At 72 h after transfection, when visible fluorescent plaques appeared, the respective virus mutant was reconstituted and harvested by three cycles of freezing and thawing. HSV-1 WT was produced by the same method using the BAC clone pYEbac102.
The mutant HSV-1 Δvhs and its revertant virus (called 'HSV-1 WT ' in Fig. 4d-f and Supplementary Fig. 4d,e ) were provided by B. Roizman (University of Chicago) and have been described previously 42 . Sendai virus (SeV, Cantell strain) was purchased from Charles River Laboratories. Influenza A/Puerto Rico/8/1934 and Δ NS1 recombinant virus were provided by A. Garcia-Sastre (Mount Sinai).
DNA constructs and transfection. FLAG-RIG-I and FLAG-GFP, cloned into the pcDNA5 FRT/TO vector, have been previously described 10 . pCMV6-Entry plasmids encoding Myc-DDK-tagged human RPL5, MRPL18, and TST were purchased from OriGene. The DNA construct encoding U6 promoter-expressed RNA5SP141 was generated by PCR using the following forward (F) and reverse (R) primers: F1 primer, 5′ -TGGAAAGGACGAAACACCGTCTACGGCCAT ACCACCCTGAACGCGCCCGATCTCGTC-3′ ; F2 primer, 5 ′ -CG CG CC CG AT-CT CG TC TG AT CT CG GA AG CT AA GCAGGGTTGGGCCTGGTTAGTACT TGGATGGGAGAAATACATCCAAAAACACGATGACTCACATG-3′ ; R primer, 5′ -CATGTGAGTCATCGTGTTTTTGGATG-3′ . The DNA construct encoding U 6 promoter-expressed RABV INT was generated u s i ng t h e f o l lo wing f o r w a rd a n d r e v e r se p r i me rs: F 1 p r i me r, 5 ′ -TGGAAAGGACGAAACACCG GGCCAGGATGGCGGCTCAAACTGCTTCTGGCCCTCCAGCCCTTGAA TGGTCGGCCACC-3′ ; R primer, 5′ -GGTGGCCGACCATTCAAGGGCT-3′ .
Transient transfection of cells was performed using calcium phosphate (Clontech), linear polyethylenimine (PEI (Polysciences) at 1 mg/ml in 10 mM Tris, pH 6. Anti-FLAG (DYKDDDDK) magnetic beads for RNA co-IP were purchased from Origene or Clontech. Protease inhibitor cocktail used for RIG-I-RNA co-IP was purchased from Sigma (cat #4693132001), and protease inhibitor cocktail used for all other experiments was purchased from Sigma (cat #P2714-1BTL).
ELISA kits for IFN-β (PBL Assay Science cat #41415-1), IL-8 (R&D Systems cat #D8000C), and CCL5 (Thermo Scientific cat #EHRNTS) were purchased and assays were performed according to the manufacturer's instructions.
LyoVec-conjugated high molecular weight (HMW) poly(I:C) was purchased from Invivogen (cat #tlrl-piclv) and was prepared according to the manufacturer's instructions.
Large-scale co-immunoprecipitation of RNA-bound RIG-I from infected cells. HEK 293T cells (~2.5 × 10 6 cells per 100 mm dish, 1 dish per sample) were transfected with constructs encoding FLAG-RIG-I or FLAG-GFP (10 μ g DNA per dish) using polyethylenimine. 24 h later, cells were infected with either HSV-1 mut (MOI 300) or SeV (50 HAU/ml) or were left uninfected. Cells were harvested 16 h later and lysed in Nonidet P-40 (NP-40) lysis buffer (50 mM HEPES, pH 7.4, 150 mM KCl, 1 mM Na 3 VO 4 , 0.5% (v/v) NP-40 and 0.5 mM Dithiothreitol (DTT, Sigma, cat #10197777001), supplemented with protease inhibitor (Sigma)) for 30 min at 4 °C. The lysates were cleared by centrifugation at 10,000 × g for 20 min at 4 °C. To co-immunoprecipitate RNA-bound FLAG-RIG-I and FLAG-GFP, cleared lysates were mixed with a 50% slurry of anti-FLAG-conjugated magnetic beads (Origene or Clontech), and the binding reaction was incubated for 4 h at 4 °C. Precipitates were washed three times with NP-40 lysis buffer and two times with high-salt wash buffer (50 mM HEPES, pH 7.5, 300 mM KCl, 1 mM Na 3 VO 4 , 0.5% (v/v) NP-40, 0.5 mM DTT, supplemented with protease inhibitor (Sigma)), followed by incubation with proteinase K (New England Biolabs) at 55 °C for 1 h. The RNA bound to FLAG-RIG-I or FLAG-GFP was extracted using phenol/ chloroform/isoamylalcohol (Amresco).
RNAseq analysis.
RNA purified from FLAG-RIG-I or FLAG-GFP precipitates from mock-infected or HSV-1 mut -infected HEK 293T cells, as well as their respective total RNA input samples, were converted into a DNA library for sequencing, both performed at the Harvard Biopolymers Facility (Boston, MA). Up to 1,000 ng total RNA was used in the Wafergen (formerly IntegenX) PrepX RNA-Seq Library Kit (cat #400039) and placed into the Wafergen Apollo, and were run using a standard protocol. PCR was performed on samples using indexed primers according to Wafergen instructions and then cleaned using the Wafergen Apollo. The resulting samples were run on an Agilent 2200 Tape Station on a D1000 High Sensitivity Tape with ladder provided to assess the integrity and overall concentration of DNA. DNA libraries were run in a qPCR assay with SYBR green KAPA SYBR FAST Universal 2X qPCR Master Mix (Kapa Biosystems, cat #KK4602) and primers to the P5 and P7 regions of the adapters. Diluted PhiX was used for the standard curve to determine concentration. Libraries passing quality control were subjected to Illumina HiSeq 2500 sequencing (Harvard Biopolymers Facility). A local Galaxy server was used to process the RNAseq data 43 . Raw sequence reads were quality trimmed using TRIM Galore! (Cutadapt 44 and FastQC wrapper 45 ) and were aligned to human herpesvirus 1 strain F (GenBank accession number GU734771, annotation converted using bp_genbank2gff3.pl) or human genome (hg38) using Tophat2 46 with settings that allowed zero mismatches in the final sequence alignment. HTSeq-count was used to calculate the induction of human and viral transcripts, and the obtained results were normalized using total count normalization 47 . Furthermore, the RIG-I-precipitate and GFP-precipitate counts were normalized to their respective input RNA. RIG-I-specific transcript enrichment was calculated by dividing the normalized RIG-I-precipitate counts through the normalized GFP-precipitate counts using R scripts. The data from two biologically independent experiments were multiplied, and visualized in R 48 using the ggplot2 package 49 .
Immunoblot analysis. Infected or transfected cells were lysed in NP-40 lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 1% (v/v) NP-40, supplemented with protease inhibitor cocktail [Sigma]), followed by centrifugation at 10,000 × g for 20 min at 4 °C to remove insoluble material. Cleared lysates were resolved on 7%, 10%, or 12% Bis-Tris SDS-PAGE gels (pH 6.4) and were subsequently transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad) using a Trans-Blot SD (Bio-Rad). Membranes were blocked with 5% (w/v) non-fat dry milk (NFDM) in PBS for 1 h, and then probed with primary antibody in antibody dilution buffer (PBS supplemented with 0.05% (v/v) Tween-20 and 5% (w/v) NFDM) at the indicated dilutions (as described above) for either 1 h at ~18-23 °C or overnight at 4 °C. Membranes were probed with goat anti-mouse-or goat anti-rabbit-HRP antibodies (Cell Signaling cat #7076 S and #7074 S, respectively) in antibody dilution buffer for 1 h at ~18-23 °C. Proteins were visualized using an enhanced chemiluminescence reagent (Pierce) and detected by Fujifilm luminescent image analyzer LAS-4000 or Amersham Imager 600. Native PAGE. HEK 293T cells, seeded into six-well plates (~3 × 10 5 cells per well), were transfected with 125 pmol of RABV Le or RNA5SP141 in vitro transcripts, or infected with SeV (50 HAU/ml). 16 h later, cells were lysed by three cycles of freeze-thaw in NP-40 lysis buffer. Native PAGE was performed as previously described 50 .
Luciferase reporter assays. HEK 293T cells were seeded into 12-well plates (~1 × 10 5 cells per well). The next day, cells were transfected with 200 ng IFN-β luciferase construct 51 and 300 ng β -galactosidase-expressing pGK-β -gal 52 , along with 5-125 ng of constructs encoding 5S rRNA-interaction proteins, or empty vector, using Lipofectamine and Plus reagent (Life Technologies), according to the manufacturer's instructions. 30 h later, cells were transfected with either no RNA or 1 pmol of in vitro-transcribed RNA5SP141 using Lipofectamine 2000 (Life Technologies), according to the manufacturer's instructions. 16 h later, cells were harvested and lysates were subjected to luciferase and β -galactosidase activity assays (both Promega). Luciferase and β -galactosidase activity was measured using a BioTek Synergy Microplate Reader in 96-well plates using 10 μ l and 25 μ l of cell lysates, respectively. Luciferase activity was normalized to β -galactosidase values, and luciferase induction was calculated relative to mock-transfected samples, set as 1.
For ISRE-luciferase assays, HEK 293T ISRE-luciferase reporter cells were seeded into 12-well plates (~1 × 10 5 cells per well) and transfected the next day with either 7 μ l of RNA retrieved from RIG-I-or GFP-precipitates, or 500 fmol of CIP-treated or untreated in vitro-transcribed t RABV Le or RNA5SP141, using Lipofectamine 2000 (Invitrogen). 16-18 h later (as indicated in the figure legends), cells were harvested and assayed for luciferase activity as described above. Induction of luciferase activity was calculated relative to mock-transfected samples, set as 1.
siRNA-mediated knockdown. Transient knockdown of endogenous RIG-I, cGAS, IFI16, RPL5, MRPL18 and TST in HEK 293T cells and NHLFs, seeded into 12-well plates (~1 × 10 5 cells per well), was achieved by transfection of gene-specific siGenome SMARTpool siRNAs (Dharmacon) with RNAiMAX transfection reagent (Invitrogen) according to the manufacturer's instructions. As a control, non-targeting siRNA (Dharmacon, D-001206-14-20) was transfected. A final concentration of 150 nM per well was used. The following siRNAs were used: siRNAs targeting RIG-I (siGENOME SMARTpool M-012511-01-0010), cGAS (siGENOME SMARTpool M-015607-01-0005), IFI16 (siGENOME SMARTpool M-020004-01-0010), RPL5 (siGENOME SMARTpool M-013611-01-0005), MRPL18 (siGENOME SMARTpool M-017251-00-0005) and TST (siGENOME SMARTpool M-010120-00-0005) (all Dharmacon). At 46-48 h after transfection (as indicated in the figure legends), knockdown efficiency was confirmed by analyzing the transcript abundance of the individual genes by qRT-PCR using specific primers (from IDT) or by determining their protein abundance by immunoblot analysis. Transient knockdown of endogenous RNA5SP141 in HEK 293T, NHLF, and AGS-EBV cells was achieved by RNAiMAX transfection of custom-made siRNA with the sense sequence 5′ -UGGGAGAAAUACAUCCAAAUU-3′ (Dharmacon). 72 h after transfection, knockdown efficiency was confirmed by analyzing the transcript levels of RNA5SP141 by qRT-PCR as described below.
In vitro RNA transcription. DNA templates for the in vitro transcription of scrambled RNA, 5S rRNA and RNA5SP141 were generated by PCR with the primers listed in Supplementary Fig. 3b using KOD Hot Start Polymerase (EMD Millipore). DNA templates for the in vitro transcription of control rabies virus leader sequence (RABV Le ) and rabies virus internal sequence (RABV INT ) were generated by annealing sense and antisense oligonucleotides as previously described 12 . RNA was synthesized using the MEGAshortscript in vitro transcription kit (Ambion) and purified using the MEGAclear transcription reaction purification kit (Ambion). RNA integrity was evaluated with the Agilent 2100 Bioanalyzer System using the Small RNA Analysis Kit (Agilent).
Phosphatase treatment of RNA. Calf intestinal alkaline phosphatase (CIP, New England Biolabs) was used according to the manufacturer's instructions to treat RABV Le and RNA5SP141 in vitro transcripts for 3 h at 37 °C. The RNA was purified using the MEGAclear kit (Ambion) and run on a 15% TBE-Urea gel to validate RNA integrity. RNAs were subsequently tested for their immunostimulatory activity by ISRE-luciferase assays as described above.
Quantitative real-time PCR (qRT-PCR).
Total RNA was purified from cells using an RNA extraction kit (Omega Bio-tek) according to the manufacturer's instructions. RNA quality was assessed using NanoDrop 2000. Equal amounts of RNA (25-500 ng) were used for a one-step qRT-PCR reaction using the SuperScript III Platinum One-Step qRT-PCR kit with ROX (Life Technologies) with commercially available FAM reporter dye primers (IDT) for the genes analyzed. Gene expression was normalized to that of 18 S (in experiments with HSV-1) or GAPDH (for all other experiments). The induction of each target gene relative to its expression in mock-infected or mock-treated cells was calculated using the comparative CT method (Δ Δ CT method).
For EBV BMRF1 transcript analysis, custom FAM reporter dye primers based on previously-described primer sequences 53 were used (forward, 5′ -CAACACCGCACTGGAGAG-3′ ; reverse, 5′ -GCCTGCTTCACTTTCTTGG-3′ ; probe, 5′ -AGGAAAAGGACATCGTCGGAGGC-3′ ) (IDT).
For RNA5SP141 transcript analysis, total RNA including small RNAs (< 200 nt) were purified from cells using the miVana miRNA isolation kit (Life Technologies). Reverse transcription (RT) and qPCR were performed using the following TaqMan MicroRNA Assays which include a target-specific RT primer and a target-specific FAM reporter dye primer: RNA5SP141 (ThermoFisher cat #CSN1ESE) and let-7a (ThermoFisher cat #4440887). Equal amounts of RNA (10-100 ng) were reversetranscribed using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) with the target-specific RT primers. cDNA was then pre-amplified using the TaqMan PreAmp Master Mix using the target-specific RT primers. qRT-PCR analysis was performed with the TaqMan Fast Advanced Master Mix (Applied Biosystems) using the target-specific TaqMan FAM reporter dye primers. The induction of RNA5SP141 relative to its expression in mock-infected or mocktreated cells was calculated using the Δ Δ CT method, normalizing to let-7a, an miRNA that is maintained at stable levels during HSV-1 infection and serves as an internal control for miRNA abundance during infection 54 . All qRT-PCR assays were performed using a 7500 FAST RT-PCR System (Applied Biosystems).
RIG-I ATPase hydrolysis assay.
The RIG-I ATPase assay was performed as previously described 55 . In brief, 250 nM in vitro-transcribed RNA was incubated with 100 nM RIG-I protein purified from insect cells (as previously described 20 ) and 3 mM unlabeled ATP, including trace amounts of [γ -32 P]ATP in EMSA buffer (5 mM MgCl, 50 mM KCl, 50 mM HEPES, 1 mM TCEP and 0.1 mg/ml BSA, pH 7) for 0, 0.5, 1, 2, or 3 h at 37 °C. Free phosphate was separated from unhydrolyzed ATP by thin-layer chromatography in TLC running buffer (1 M formic acid, 0.5 M LiCl) on polyethyleneimine cellulose TLC plates (Sigma-Aldrich). [γ -32 P]Pi and [γ -32 P]ATP were detected using a phosphor-imaging system (GE Healthcare) and quantified using ImageJ, and the proportion of hydrolyzed ATP for every time point was calculated. The average value of three replicates was calculated and average hydrolyzed ATP was plotted against time.
Cytoplasmic-nuclear fractionation assay. HEK 293T cells were seeded into 6-well plates (~3 × 10 5 cells per well). The next day, cells were infected with HSV-1 (MOI 1) or SeV (50 HA units/ml) for 16 h or left uninfected. Cells were fractionated using the Ambion PARIS fractionation kit according to the manufacturer's instructions. In brief, cell pellets were lysed in cell fractionation buffer on ice for 15 min and subjected to low-speed centrifugation to pellet nuclei. The supernatant (cytoplasmic fraction) was removed, and nuclear pellets were lysed in cell disruption buffer. Lysates from each fraction were divided into two equal samples and used for protein and RNA purification. Fractionated protein lysates were subjected to immunoblot analysis to assess the abundance of the nuclear protein lamin A/C and the cytoplasmic protein β -tubulin. Fractionated RNA samples were subjected to qRT-PCR analysis to assess the abundance of nuclear RNA markers (MALAT1, NEAT1 and RNU2-1) and RNA5SP141 transcripts in each fraction.
RNA-precipitation assay. For purification of endogenous RNA5SP141 from total cellular RNA, 3′ -biotinylated LNA oligonucleotides (Exiqon) with the following sequences were used: scramble, 5′ -AGTTCCGTGCGTCGACTAGGA-3′ /3BioTEG/; U1, 5′ -TACCACAAATTATGCAGTCGA-3′ /3BioTEG/; and RNA5SP141, 5'-ATGTGAGTCATCGTGTTT-3′ /3BioTEG/. For each sample, 50 μ g of phenol-chloroform-purified total cell RNA was incubated with 375 pmol LNA oligonucleotides for 30 min at ~18-23 °C. Next, MyONE Streptavidin C1 magnetic beads (ThermoFisher cat #65002) were added to the samples and incubated for 30 min at 25 °C. Beads were washed using buffers from the Dynabeads mRNA DIRECT Kit (Life Technologies cat #61011) according to the manufacturer's instructions, and RNA was eluted from the beads by incubation at 65 °C for 2 min.
For precipitation of 5S rRNA-interacting proteins, biotinylated scramble RNA, 5S rRNA, and RNA5SP141 ( Supplementary Fig. 3b ) were transcribed in vitro using a Biotin-16-UTP RNA labeling mix (Roche), and RNA was purified using the MEGAclear transcription reaction purification kit (Ambion). RNA binding of 5S rRNA-interacting proteins was assessed by streptavidin precipitation as previously described 56 . In brief, one to four 10-cm dishes of HEK 293T cells per sample were each transfected with 15 μ g of FLAG-RPL5, FLAG-MRPL18, or FLAG-TST. 48 h after transfection, cells were lysed in NP-40 lysis buffer supplemented with protease inhibitor (Sigma) and cleared by centrifugation at 10,000 × g for 20 min at 4 °C. Cell lysates were incubated for 1 h at 22 °C with no RNA or 1 μ g of biotinylated scramble RNA, 5S rRNA or RNA5SP141. Samples were incubated with a 50% slurry of streptavidin agarose (Pierce) for 2 h at 4 °C and washed extensively with NP-40 lysis buffer. Whole-cell lysates and precipitated samples were subjected to immunoblot analysis to assess the expression and binding of FLAG-tagged RPL5, MRPL18 and TST, respectively.
RNA secondary structure prediction. Prediction of RNA5SP141 secondary structure was performed using the Vienna RNAfold web server 57 using standard settings.
LNA gapmer-mediated knockdown. Transient knockdown of endogenous RIG-I and RNA5SP141 in HEK 293T and NHLF cells, seeded into 24-well plates (~5 × 10 4 cells per well), was achieved by transfection of gene-specific LNA gapmers (Exiqon) with Lipofectamine 3000 transfection reagent (Invitrogen) according to the manufacturer's instructions at a final concentration of 50 nM LNA gapmer per well. Non-targeting scrambled antisense LNA gapmer (Exiqon, cat #300610) was transfected as a negative control. Custom-made LNA gapmers with the following sequences were used: RIG-I_1: 5′ -CAAATGCGCAGAGGTC-3′ , RIG-I_2: 5′ -TCGGTTGGGATAATTC-3′ , RNA5SP141_1: 5′ -CATGTGAGTCATCGTG-3′ , RNA5SP141_2: 5′ -TTTGGATGTATTTCTC-3′ . At 72 h after transfection, knockdown efficiency was confirmed by analysis of the transcript abundance of the individual genes by qRT-PCR using specific primers (IDT).
Statistical analysis. Unpaired two-tailed Student's t-tests were used to compare differences between two unpaired experimental groups in all cases. A P value of < 0.05 was considered statistically significant. Biological replicates consisted of individual cell cultures. No pre-specified effect size was assumed and in general two to three replicates for each condition were used, which was sufficient to demonstrate statistically significant differences.
Life Sciences Reporting Summary. Further information on experimental design and reagents is available in the Life Sciences Reporting Summary.
Data availability. The data that support the findings of this study are available from the corresponding author upon request. The RNAseq data from this study are deposited in NCBI GEO under accession code GSE95623. Corresponding author(s): Michaela U. Gack
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